Association between NOD2 and autoinflammation presenting as Yellow Nail Syndrome
Abstract
Background: Yellow Nail Syndrome is defined as a triad of lymphedema, respiratory symptoms, and nail discolouration. The precise etiology remains unknown, however it has been reported alongside a broad spectrum of conditions including malignancies, autoinflammatory diseases, and immunodeficiencies.
Aim: To highlight the association between defects in the intracellular bacterial sensor gene NOD2 and Yellow Nail Syndrome.
Methods: A retrospective review of the patient’s chart was performed, including family history, characteristics, immune laboratory evaluation, and genetics.
Results: A 65-year-old female was referred to our centre for lymphedema and bronchiectasis. She had recurrent episodes of pneumonia, cellulitis, and oral ulcers. Bilateral lymphedema on her lower limbs up to the hip and discoloured yellow nails were reported. Given her clinical picture, she was diagnosed with Yellow Nail Syndrome. The immunological evaluation was unremarkable overall, with normal T cell subsets and function and adequate antibody titers. Genetic testing identified a heterozygous mutation in the NOD2 gene, c.2107C>T (p.Arg703Cys), considered a variant of uncertain significance.
Conclusion: Heterozygous variants in NOD2 can result in a spectrum of autoimmune and autoinflammatory disorders, including Yellow Nail Syndrome.
Statement of novelty: We describe a patient with Yellow Nail Syndrome, presenting with the classic triad of clinical features. Genetic evaluation identified a heterozygous variant in NOD2, which has been extensively associated with several autoinflammatory diseases, but not Yellow Nail Syndrome.
Formats available
You can view the full content in the following formats:
REFERENCES
Aksentijevich I. 2015. Update on genetics and pathogenesis of autoinflammatory diseases: the last 2 years. Semin. Immunopathol. 37: 395–401.
Brice G. 2002. Analysis of the phenotypic abnormalities in lymphoedema-distichiasis syndrome in 74 patients with FOXC2 mutations or linkage to 16q24. J. Med. Genet. 39: 478–483.
Emerson P.A. 1966. Yellow nails, lymphoedema, and pleural effusions. Thorax, 21: 247–253.
Finegold D.N., Kimak M.A., Lawrence E.C., Levinson K.L., Cherniske E.M., Pober B.R., Dunlap J.W., and Ferrell R.E. 2001. Truncating mutations in FOXC2 cause multiple lymphedema syndromes. Hum. Mol. Genet. 10: 1185–1189.
Gupta S., Samra D., Yel L., and Agrawal S. 2012. T and B Cell Deficiency Associated with Yellow Nail Syndrome. Scand. J. Immunol. 75: 329–335.
Hiller E., Rosenow E.C., and Olsen A.M. 1972. Pulmonary Manifestations of the Yellow Nail Syndrome. Chest, 61: 452–458.
Hoque S.R., Mansour S., and Mortimer P.S. 2007. Yellow nail syndrome: not a genetic disorder? Eleven new cases and a review of the literature. Br. J. Dermatol. 156: 1230–1234.
Hugot J.P., Chamaillard M., Zouali H., Lesage S., Cezard J.P., Belaiche J., Almer S., Tysk C., O’morain C.A., Gassull M., Binder V., Finkel Y., Cortot A., Modigliani R., Laurent-Puig P., Gower-Rousseau C., Macry J., Colombel J.F., Sahbatou M., and Thomas G. 2001. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn’s disease. Nature, 411: 599–603.
King K., Sheikh M.F., Cuthbert A.P., Fisher S.A., Onnie C.M., Mirza M.M., Pattni R.C., Sanderson J., Forbes A., Mansfield J., Lewis C.M., Roberts R.G., and Mathew C.G. 2006. Mutation, selection, and evolution of the Crohn disease susceptibility gene CARD15. Hum. Mutat. 27: 44–54.
Maekawa S., Ohto U., Shibata T., Miyake K., and Shimizu T. 2016. Crystal structure of NOD2 and its implications in human disease. Nat. Commun. 7: 11813.
Maldonado F., Tazelaar H.D., Wang C.-W., and Ryu J.H. 2008. Yellow Nail Syndrome. Chest, 134: 375–381.
Miceli-Richard C., Lesage S., Rybojad M., Prieur A.M., Manouvrier-Hanu S., Hafner R., Chamaillard M., Zouali H., Thomas G., and Hugot J.P. 2001. CARD15 mutations in Blau syndrome. Nat. Genet. 29: 19–20.
Negroni A., Pierdomenico M., Cucchiara S., and Stronati L. 2018. NOD2 and inflammation: current insights. J. Inflamm. Res., 11: 49–60.
Ogura Y., Bonen D.K., Inohara N., Nicolae D.L., Chen F.F., Ramos R., Britton H., Moran T., Karaliuskas R., Duerr R.H., Achkar J.P., Brant S.R., Bayless T.M., Kirschner B.S., Hanauer S.B., Nunez G., and Cho J.H. 2001. A frameshift mutation in NOD2 associated with susceptibility to Crohn’s disease. Nature, 411: 603–606.
Piraccini B.M., Urciuoli B., Starace M., Tosti A., and Balestri R. 2014. Yellow nail syndrome: Clinical experience in a series of 21 patients. JDDG: J. Dtsch. Dermatol. Ges. 12: 131–137.
Samman P.D. and White W.F. 1964. The “Yellow Nail” Syndrome. Br. J. Dermatol. 76: 153–157.
Siegelman S.S., Heckman B.H., and Hasson J. 1969. Lymphedema, Pleural Effusions and Yellow Nails. Dis. Chest. 56: 114–117.
Tanabe T., Chamaillard M., Ogura Y., ZHU L., Qiu S., Masumoto J., Ghosh P., Moran A., Predergast M.M., Tromp G., Williams C.J., Inohara N., and Núñez G. 2004. Regulatory regions and critical residues of NOD2 involved in muramyl dipeptide recognition. EMBO J. 23: 1587–1597.
Tangye S.G., Al-Herz W., Bousfiha A., Cunningham-Rundles C., Franco J.L., Holland S.M., Klein C., Morio T., Oksenhendler E., Picard C., Puel A., Puck J., Seppänen M.R.J., Somech R., Su H.C., Sullivan K.E., Torgerson T.R., and Meyts I. 2022. Human Inborn Errors of Immunity: 2022 Update on the Classification from the International Union of Immunological Societies Expert Committee. J. Clin. Immunol. 24: 1–35.
Vignes S. and Baran R. 2017. Yellow nail syndrome: a review. Orphanet. J. Rare. Dis. 12(1): 42.
Yao Q., Li E., and Shen B. 2019. Autoinflammatory disease with focus on NOD2-associated disease in the era of genomic medicine. Autoimmunity, 52: 48–56.
Yao Q., Su L.-C., Tomecki K.J., Zhou L., Jayakar B., and Shen B. 2013. Dermatitis as a characteristic phenotype of a new autoinflammatory disease associated with NOD2 mutations. J. Am. Acad. Dermatol. 68: 624–631.
Yao Q., Zhou L., Cusumano P., Bose N., Piliang M., Jayakar B., Su L.C., and Shen B. 2011. A new category of autoinflammatory disease associated with NOD2 gene mutations. Arthritis. Res. Ther. 13: R148.
Information & Authors
Information
Published In
LymphoSign Journal
Volume 9 • Number 3 • September 2022
Pages: 67 - 71
History
Received: 21 August 2022
Accepted: 28 August 2022
Accepted manuscript online: 30 August 2022
Copyright
© 2022.
Authors
Metrics & Citations
Metrics
Other Metrics
Citations
Cite As
Laura EdithAbrego Fuentes and MohammadAlsalamah. 2022. Association between NOD2 and autoinflammation presenting as Yellow Nail Syndrome. LymphoSign Journal.
9(3): 67-71. https://doi.org/10.14785/lymphosign-2022-0011
Export Citations
If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.
There are no citations for this item
View Options
Get Access
Login options
Check if you access through your login credentials or your institution to get full access on this article.
